Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
01 1Chunghwa Chemical Synthesis & Biotech. Ltd
02 1Ash Stevens LLC
03 1MSN Laboratories Private Limited
01 1IXAZOMIB CITRATE
02 2Ixazomib Citrate
01 1India
02 1Taiwan
03 1U.S.A
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6224
Start Marketing Date : 2017-01-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48957-0056
Start Marketing Date : 2015-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0084
Start Marketing Date : 2019-01-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ixazomib Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ixazomib Citrate, including repackagers and relabelers. The FDA regulates Ixazomib Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ixazomib Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ixazomib Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ixazomib Citrate supplier is an individual or a company that provides Ixazomib Citrate active pharmaceutical ingredient (API) or Ixazomib Citrate finished formulations upon request. The Ixazomib Citrate suppliers may include Ixazomib Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Ixazomib Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ixazomib Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ixazomib Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ixazomib Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ixazomib Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ixazomib Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ixazomib Citrate suppliers with NDC on PharmaCompass.
We have 3 companies offering Ixazomib Citrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
